Clinical Trial Update: Intravitreal Microplasmin in Patients Undergoing Surgical Vitrectomy [Phase 2]

View source ↗

Summary

Phase 2 trial update on intravitreal microplasmin for vitreomacular traction during vitrectomy has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Vitreomacular Traction Syndrome

Drugs mentioned

• Jetrea (ocriplasmin)

Snippet

Sponsor: ThromboGenics | Conditions: Vitreomacular Traction Maculopathy, Eye Diseases | Phase 2 | Status: COMPLETED